Carbohydrate Drinks for Surgery Preparation
(CIPS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores the effects of a specialized carbohydrate drink on individuals undergoing major urologic surgery. The researchers aim to determine if consuming UCAN SuperStarch before surgery improves health outcomes compared to a standard sports drink like Gatorade. Participants will wear a glucose monitor to track blood sugar levels before, during, and after surgery. Adults who can swallow liquids, speak English, and are scheduled for major urologic surgery lasting more than four hours may qualify for this trial. As an unphased study, this trial offers a unique opportunity to contribute to innovative research that could enhance surgical recovery for future patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that UCAN SuperStarch is generally safe for people. Studies have found that consuming carbohydrate drinks like SuperStarch before surgery can be safe and might help with insulin resistance, a condition where the body doesn't use insulin effectively. This could improve sugar management during and after surgery.
Reports from similar studies suggest no major safety concerns with using SuperStarch before surgery. Although some studies indicate that more research is needed, SuperStarch is considered likely safe for surgical preparation. Overall, existing evidence supports its safety for surgical patients.12345Why are researchers excited about this trial?
Researchers are excited about the trial for carbohydrate drinks in surgery preparation because it explores how UCAN SuperStarch compares to traditional options like Gatorade. Unlike typical carbohydrate drinks that cause quick spikes and crashes in blood sugar levels, UCAN SuperStarch provides a steady release of energy. This could help maintain stable blood sugar levels before surgery, potentially improving patient outcomes and recovery times. By understanding the effects of different carbohydrate sources, this trial might lead to more effective pre-surgery nutrition protocols.
What evidence suggests that this trial's treatments could be effective for surgery preparation?
Research has shown that consuming carbohydrate-rich beverages before surgery can improve recovery. These drinks help maintain steady blood sugar levels, reduce stress, and increase comfort post-surgery. Patients who consumed these beverages reported feeling less thirsty and tired and demonstrated better focus. Specifically, drinks with more than 50 grams of carbohydrates proved more effective than those with less. In this trial, participants will receive either UCAN SuperStarch or Gatorade as part of their preparation. UCAN SuperStarch is a specialized carbohydrate designed to support these pre-surgery benefits.46789
Who Is on the Research Team?
Jill M. Hamilton-Reeves
Principal Investigator
University of Kansas Medical Center
Are You a Good Fit for This Trial?
Adults over 18 scheduled for major urologic surgery lasting more than 4 hours can join this trial. They must be able to drink liquids and speak English.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Preoperative Carbohydrate Loading
Participants consume a specialized carbohydrate drink the night before and 2-3 hours before surgery
Surgery and Immediate Postoperative Monitoring
Participants undergo surgery and are monitored for glycemic variability and other metabolic markers
Follow-up
Participants are monitored for post-operative complications and clinical outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Gatorade
- UCAN SuperStarch
UCAN SuperStarch is already approved in United States for the following indications:
- Preoperative carbohydrate loading for surgical patients
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Kansas Medical Center
Lead Sponsor